| Date Filed | Type | Description |
| 07/18/2023 |
4
| Sarnoff David (Director) has filed a Form 4 on Hoth Therapeutics, Inc.|
Txns:
| Granted 7,500 options
@ $2.59, valued at
$19.4k
|
|
| 07/18/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/18/2023 |
4
| Knie Robb (CEO and President) has filed a Form 4 on Hoth Therapeutics, Inc.|
Txns:
| Granted 40,000 options
@ $2.59, valued at
$103.6k
|
|
| 07/18/2023 |
4
| Pavell Jeff (Director) has filed a Form 4 on Hoth Therapeutics, Inc.|
Txns:
| Granted 7,500 options
@ $2.59, valued at
$19.4k
|
|
| 07/18/2023 |
4
| Linsley Wayne (Director) has filed a Form 4 on Hoth Therapeutics, Inc.|
Txns:
| Granted 7,500 options
@ $2.59, valued at
$19.4k
|
|
| 12/13/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/13/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 09/20/2022 |
4
| Knie Robb (CEO and President) has filed a Form 4 on Hoth Therapeutics, Inc.|
Txns:
| Bought 10,000 shares
@ $0.39, valued at
$3.9k
|
|
| 09/19/2022 |
4
| Knie Robb (CEO and President) has filed a Form 4 on Hoth Therapeutics, Inc.|
Txns:
| Bought 10,000 shares
@ $0.4, valued at
$4k
|
|
| 03/18/2022 |
4
| Knie Robb (CEO and President) has filed a Form 4 on Hoth Therapeutics, Inc.|
Txns:
| Granted 500,000 options
@ $0.591, valued at
$295.5k
|
|
| 03/18/2022 |
4
| Johns Stefanie (Chief Scientific Officer) has filed a Form 4 on Hoth Therapeutics, Inc.|
Txns:
| Granted 250,000 options
@ $0.591, valued at
$147.8k
|
|
| 03/18/2022 |
4
| Sarnoff David (Director) has filed a Form 4 on Hoth Therapeutics, Inc.|
Txns:
| Granted 40,000 options
@ $0.591, valued at
$23.6k
|
|
| 03/18/2022 |
4
| Springer Graig (Director) has filed a Form 4 on Hoth Therapeutics, Inc.|
Txns:
| Granted 40,000 options
@ $0.591, valued at
$23.6k
Granted 250,000 options
@ $0.591, valued at
$147.8k
|
|
| 03/18/2022 |
4
| Linsley Wayne (Director) has filed a Form 4 on Hoth Therapeutics, Inc.|
Txns:
| Granted 40,000 options
@ $0.591, valued at
$23.6k
|
|
| 02/16/2021 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 02/01/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/01/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/01/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/01/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/01/2021 |
4
| Knie Robb (CEO and President) has filed a Form 4 on Hoth Therapeutics, Inc.|
Txns:
| Granted 225,000 options
@ $2.11, valued at
$474.8k
|
|
| 02/01/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/09/2020 |
3
| Johns Stefanie (Chief Scientific Officer) has filed a Form 3 on Hoth Therapeutics, Inc. |
| 07/23/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/23/2020 |
4
| Knie Robb (CEO and President) has filed a Form 4 on Hoth Therapeutics, Inc.|
Txns:
| Granted 80,000 options
@ $3.05, valued at
$244k
|
|
| 07/23/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/23/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/23/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/23/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/29/2020 |
4
| Hayes Anthony (10% Owner) has filed a Form 4 on Hoth Therapeutics, Inc.|
Txns:
| Sold 400,000 shares
@ $1.25, valued at
$500k
|
|
| 04/17/2020 |
4
| Linsley Wayne (Director) has filed a Form 4 on Hoth Therapeutics, Inc.|
Txns:
| Granted 3,333 shares
@ $0 |
|
| 04/17/2020 |
3
| Linsley Wayne (Director) has filed a Form 3 on Hoth Therapeutics, Inc. |
| 04/16/2020 |
4
| Springer Graig (Director) has filed a Form 4 on Hoth Therapeutics, Inc.|
Txns:
| Granted 3,333 shares
@ $0 |
|
| 03/04/2020 |
3
| Springer Graig (Director) has filed a Form 3 on Hoth Therapeutics, Inc. |
| 12/26/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|